Phase 1 Reversal of Neuromuscular Blockade Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Single Ascending Dose of HRS-2162 in Healthy Subjects

Reversal of Neuromuscular Blockade

Fujian Shengdi Pharmaceutical Co., Ltd.64 enrolled1 locationNCT07195604

Recruiting

Phase 1Phase 2

Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade

Recovery TimeNeuromuscular Blocking AgentsReversal of Neuromuscular Blockade

Universitas Padjadjaran60 enrolled1 locationNCT06794450